Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 9
  1. Jun 09, 2026 · 07:00 · MBIO · Routine +

    From failed psychedelics to unproven AI kiosks: MindBio bets its survival on voice analytics, but cash burn and dilution loom.

    MindBio Completes Manufacture and Delivery of First Prototype Edge AI Intoxication and Fatigue Detection Kiosks

    01
  2. Jun 09, 2026 · 06:00 · LOBE · Neutral

    Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares

    Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares

    02
  3. Jun 08, 2026 · 21:30 · APTX · Routine +

    Apotex Health Secures $1.3B via IPO Upsize, Balancing Treasury Growth Capital with $450M Secondary Liquidity

    APOTEX HEALTH CORP. UPSIZES ITS INITIAL PUBLIC OFFERING

    03
  4. Jun 08, 2026 · 17:58 · TELY · Routine +

    Digital Pharmacy Scales to 1M Prescriptions, But Growth Trajectory Faces Liquidity and Profitability Tests

    Telyrx Holdings fills over one million prescriptions

    04
  5. Jun 08, 2026 · 09:12 · EKG · Neutral

    Micro-cap ECG software developer pivoting to AI-driven remote monitoring amid persistent cash burn and negative equity.

    CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration

    05
  6. Jun 08, 2026 · 08:01 · TELY · Routine +

    Scaling a cash-pay digital pharmacy model, but liquidity and profitability remain unproven as the stock drifts lower post-IPO.

    TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy

    06
  7. Jun 08, 2026 · 08:00 · 4875 · Routine +

    Late-stage biotech advancing MN-166 across neurology and oncology, with patent wins reinforcing IP moats while pivotal clinical data remains pending.

    MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

    07
  8. Jun 08, 2026 · 08:00 · AIDR · Routine +

    Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

    Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

    08
  9. Jun 08, 2026 · 07:00 · MRVL · Routine +

    Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

    Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

    09
  10. Jun 05, 2026 · 18:00 · ONCO · Neutral

    Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program

    Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program

    10
  11. Jun 05, 2026 · 18:00 · GUD · Routine +

    Knight Announces Early Warning Filing Regarding Shares of Crescita

    Knight Announces Early Warning Filing Regarding Shares of Crescita

    11
  12. Jun 05, 2026 · 17:00 · PHA · Material −

    Premier Health of America Announces Grant of Management Cease Trade Order

    Premier Health of America Announces Grant of Management Cease Trade Order

    12
  13. Jun 05, 2026 · 16:20 · NVRS · Neutral

    Noveris Health Sciences Re-Engages R&D Partner on Psilocybin Pipeline Amid Stem Cell Pivot and Insider Sell-Off

    Noveris Health Sciences Provides Corporate Update

    13
  14. Jun 05, 2026 · 16:15 · EXE · Routine +

    Extendicare Joins TSX Composite as Home Health Merger Drives Scale and Investment-Grade Upgrade

    S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

    14
← Newer Older →